Skip to content

13F-HR filed by ORACLE INVESTMENT MANAGEMENT INC

ORACLE INVESTMENT MANAGEMENT INC filed this 13F-HR for the quarter ended 2021-03-31, filed 2021-05-17, with 28 holding rows worth $667,755,000.

Accession
0001085146-21-001783
Filed
2021-05-17
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2021

A holdings report, 28 entries on the cover page, a total value of $667,755,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $667,755,000 with VALUE read as thousands by filing date, 13F file number 028-05592. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
BIOHAVEN PHARMACEUTICAL HOLDING11196105COM2,123,271$145,126,000thousands by filing date
QUIDEL CORP74838J101COM1,090,309$139,483,000thousands by filing date
ASPIRA WOMENS HEALTH INC04537Y109COM8,647,094$58,368,000thousands by filing date
OPKO HEALTH INC68375N103COM12,821,273$55,003,000thousands by filing date
PACIFIC BIOSCIENCES CALIF INC COM69404D108Stock1,446,459$48,182,000thousands by filing date
DERMTECH INC24984K105COM713,577$36,243,000thousands by filing date
Accelerate Diagnostics00430H102COM3,776,121$31,417,000thousands by filing date
AGENUS INC00847G705COM NEW9,373,582$25,496,000thousands by filing date
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock2,367,670$24,079,000thousands by filing date
VIR BIOTECHNOLOGY INC92764N102COM450,331$23,088,000thousands by filing date
AMARIN CORP PLC023111206SPONS ADR NEW2,084,839$12,947,000thousands by filing date
Y-mAbs Therapeutics Inc984241109Common Stock380,642$11,511,000thousands by filing date
CAPRICOR THERAPEUTICS INC14070B309COMMON STOCK1,999,464$9,357,000thousands by filing date
CODIAK BIOSCIENCES INC192010106COM545,360$8,224,000thousands by filing date
ANTARES PHARMA INC036642106COM1,900,000$7,809,000thousands by filing date
SELECT MED HLDGS CORP81619Q105COM225,000$7,673,000thousands by filing date
CONTRAFECT CORP212326300COM1,552,423$7,452,000thousands by filing date
BIODESIX INC09075X108COM235,511$4,783,000thousands by filing date
MOTUS GI HLDGS INC62014P108COM3,747,551$4,535,000thousands by filing date
SOLENO THERAPEUTIVS, INC.834203200COMM2,132,000$2,686,000thousands by filing date
FORIAN INC34630N106cs155,440$1,571,000thousands by filing date
BIOGEN INC COM09062X103Stock2,412$675,000thousands by filing date
SELECT MED HLDGS CORP81619Q105COM100,000$585,000thousands by filing dateput
PACIFIC BIOSCIENCES CALIF INC COM69404D108Stock100,000$505,000thousands by filing dateput
QUIDEL CORP74838J101COM50,000$363,000thousands by filing dateput
DERMTECH INC24984K105COM46,900$356,000thousands by filing dateput
VIR BIOTECHNOLOGY INC92764N102COM19,000$221,000thousands by filing dateput
BIOHAVEN PHARMACEUTICAL HOLDING11196105COM33,600$17,000thousands by filing dateput

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001085146-21-001783this filing2021-05-17acceptance time not in the bulk data set